Do drug company promotions influence physician behavior?

This publication has 9 references indexed in Scilit:

• Health outcomes associated with calcium antagonists compared with other first-line antihypertensive therapies: a meta-analysis of randomised controlled trials
  The Lancet, 2000
• Financial Indigestion
  JAMA, 2000
• A physician survey of the effect of drug sample availability on physicians’ behavior
  Journal of General Internal Medicine, 2000
• Trends in antihypertensive drug use in the United States: do the JNC V recommendations affect prescribing? Fifth Joint National Commission on the Detection, Evaluation, and Treatment of High Blood Pressure
  Published by American Medical Association (AMA) ,1997
• The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure
  Archives of internal medicine (1960), 1997
• Physicians' behavior and their interactions with drug companies. A controlled study of physicians who requested additions to a hospital drug formulary.
  1994
• The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V)
  Archives of internal medicine (1960), 1993
• The Effects of Pharmaceutical Firm Enticements on Physician Prescribing Patterns
  Chest, 1992
• Scientific versus commercial sources of influence on the prescribing behavior of physicians
  The American Journal of Medicine, 1982